Pulmonary lymphangiogenesis promotes lung B cell responses and bronchus-associated lymphoid tissue (BALT) initiation in chronic allergic asthmaJOURNAL OF IMMUNOLOGYIF3.42025-11-010PRE
Liver-targeted allergen immunotherapy rapidly and safely induces antigen-specific tolerance to treat allergic airway disease in miceScience Translational MedicineIF14.62025-01-010OA
Engineered IL-7 synergizes with IL-12 immunotherapy to prevent T cell exhaustion and promote memory without exacerbating toxicitySCIENCE ADVANCESIF12.52023-12-014OAAI
Membrane-localized neoantigens predict the efficacy of cancer immunotherapyCELL REPORTS MEDICINEIF10.62023-08-010OAAI
Prophylactic and therapeutic use of synthetically glycosylated antigens to limit allergic airway diseaseJOURNAL OF IMMUNOLOGYIF3.42023-05-010OA
LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockadeJOURNAL OF CLINICAL INVESTIGATIONIF13.62022-07-0123OAAI
VEGFR3-driven pulmonary lymphangiogenesis exacerbates induction of bronchus-associated lymphoid tissue in allergic airway diseaseJOURNAL OF IMMUNOLOGYIF3.42022-05-010PRE